Resumen de Investigación

Continuous Glucose Monitoring Improves Glycemic Control in Diabetes

Moderate confidence
Low bias
Última actualización 15 de junio de 2026

Conclusión Clave:

This study examined the impact of continuous glucose monitoring on glycemic control in diabetes patients, finding significant reductions in HbA1c and fasting plasma glucose levels.

Estudio de un Vistazo

Participantes

Intervención

Continuous glucose monitoring

Resultados

HbA1c, Fasting blood sugar (FBS), Body mass index (BMI), Total cholesterol

Financiamiento

No Patrocinado por la Industria

Guarda este estudio y agrega notas a tu biblioteca de investigación.

Efectos Principales

HbA1c decreased from 8.09% to 7.48% (p < 0.001)

Fasting plasma glucose decreased from 152.41 mg/dL to 137.16 mg/dL (p < 0.001)

Total cholesterol decreased from 149.77 mg/dL to 146.95 mg/dL (p = 0.036)

Resumen de Evidencia

InterventionOutcomeMeasured ChangeStudy Effect
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Weight & Anthropometrics
BMI
(Weight & Anthropometrics)
No Change
Unclear
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Glycemic Control
Fasting blood sugar (FBS)
(Glycemic Control)
Decrease
Strong
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Glycemic Control
HbA1c
(Glycemic Control)
Decrease
Strong
Devices & Technology
Continuous glucose monitoring
(Devices & Technology)
Metabolic Health
Total cholesterol
(Metabolic Health)
Decrease
Strong

Unlock Full Evidence Analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

La Evidencia Sugiere

  • HbA1c decreased by 0.61% (p < 0.001).
  • Fasting plasma glucose decreased by 15.25 mg/dL (p < 0.001).
  • Total cholesterol decreased by 2.82 mg/dL (p = 0.036).
who this applies

A quién se aplica

  • Adults diagnosed with diabetes mellitus.
  • Patients using continuous glucose monitoring devices.
keep in mind

Tener en Cuenta

  • Results may not be generalizable to all diabetes populations.
  • The increase in body mass index was not statistically significant.
  • Further research is needed to confirm long-term effects.
between the lines

Entre Líneas

  • Study design was non-randomized, limiting causal inference.
  • Sample size and demographic details were not specified.
  • Potential confounding factors were not controlled.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Referencia de la Revista

Mi-Joon L, Bum-Jeun S, Jae-Hyoung C, Daniela MT, Mariana F, Ionela LS. The Effects of Continuous Glucose Monitoring on Glycemic Control in Patients with Diabetes Mellitus. Life. 2025;15(10):1543. doi:10.3390/life15101543

Connected Evidence

Discover how this study fits into the broader diabetes evidence landscape.

This study contributes to evidence on Continuous Glucose Monitoring and Glycemic Control, Continuous Glucose Monitoring and Glycemic Control.

Relaciones de evidencia relacionadas

Explore in Evidence Archive

This study contributes to the evidence on the following intervention–outcome relationships.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.